From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary
June 2019 Volume 154, Supplement 1, Page 225
Abandoning the HPV vaccine in Japan due to safety concerns-where is the evidence?
CI Liao, DA Klein, AK Mann, DS Kapp, JK Chan –
Objective: The reported HPV vaccine rates in Japan have dropped from 70% to near zero because of concerns of safety. We proposed to compare the regional and systemic safety profiles of HPV vaccine in Japanese versus whites in a meta-analysis to address these beliefs.
Cancer Treatment Reviews
Volume 78, August 2019, Pages 8-16
The Promise of Combining Cancer Vaccine and Checkpoint Blockade for Treating HPV-Related Cancer
T Shibata, BJ Lieblong, T Sasagawa, M Nakagawa – 2019
:: HPV have ingenious immune suppressive mechanisms.
:: Checkpoint inhibitors have little efficacy against HPV-associated cancers.
:: HPV therapeutic vaccines have little efficacy against HPV-associated cancers.
:: However, combining these two therapeutic modalities is starting to show promise.
:: Epitope spreading may play a critical role mechanistically in this combination.